November 29, 2025
Round numbers, sharp consequences
The risk of round numbers and sharp thresholds in clinical practice
When “3.5” feels safe but hides danger—readers roast one-size-fits-all care
TLDR: New research says hospital “round-number” cutoffs like a creatinine of 3.5 can mislead treatment and create avoidable risk. Comments split between “obvious, tautology” skeptics, parenting lessons on dosing, and publication gossip—consensus lands on smarter, more patient-specific thresholds being crucial
Doctors love neat rules, and ICU scorecards (APACHE II and SOFA—two risk scores) famously use tidy cutoffs like a creatinine of 3.5. This paper says those “round-number cliffs” can warp reality: patients just below the line may miss helpful treatment, while those just above get it, skewing outcomes. Using transparent (“glass-box”) machine learning, the authors claim they can spot weird patterns—like risk dropping after the threshold—and call out where medicine’s rule-of-thumb needs a tune-up. Real-world data from MIMIC-IV even shows risk peaking near a threshold, then dipping, raising eyebrows.
The comments? On fire. Terretta cheers that this applies to any metric-driven system, while avidiax rolls eyes, calling the “paradoxical risk” basically obvious when treatment is yes/no: of course treated people near the line can outperform untreated ones. uniqueuid brings parenting energy with Tylenol tales—kids need dosing by weight, not age-boxes—aka “round numbers, real consequences.” Then bonsai_spool stirs meta-drama: praising the work but hinting it bounced from big-name journals, with a 2-year-old GitHub repo and a “not very popular” publication. Cue the meme of “vibes-based medicine vs. chaos-free checklists.” The crowd splits between personalized care fans and busy ward realists, but everyone agrees: numbers shouldn’t be magic wands
Key Points
- •Round-number thresholds in clinical guidelines can misalign with statistically optimal decision points, increasing patient risk.
- •APACHE II and SOFA use a serum creatinine threshold of 3.5 mg/dL, illustrating potential distortion in risk-based treatment decisions.
- •Observed data (e.g., MIMIC-IV) show risk peaking at a threshold and then decreasing, contradicting model predictions of monotonic increase.
- •Glass-box machine learning methods are introduced to detect artifacts of threshold-based decision making in observational data.
- •Statistical tests target two artifact types: discontinuous risk at thresholds and paradoxical risk due to effective treatments.